1. Current status of type 1 (IgG4-related) autoimmune pancreatitis

   • Kazushige Uchida
   • Kazuichi Okazaki

   Review Open access 02 August 2022 Pages: 695 - 708

   

2. Evidence-based clinical practice guidelines for chronic pancreatitis 2021

   • Kyoko Shimizu
   • Tetsuhide Ito
   • Kazuhiko Koike

   Review Open access 22 August 2022 Pages: 709 - 724

   

3. Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma

   • Yoichi Akazawa
   • Hiroya Ueyama
   • Akihito Nagahara

   Original Article—Alimentary Tract 08 August 2022 Pages: 725 - 734

   

4. Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017

   • Adam C. Bledsoe
   • John J. Garber
   • Jonas F. Ludvigsson

   Original Article—Alimentary Tract Open access 19 July 2022 Pages: 735 - 747

   

5. Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation

   • Yukari Tanaka
   • Riu Yamashita
   • Shin Fukudo

   Original Article—Alimentary Tract Open access 30 July 2022 Pages: 748 - 760

   

6. Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study

   • Kristine H. Allin
   • Camilla B. Jensen
   • Tine Jess

   Original Article—Alimentary Tract 02 July 2022 Pages: 761 - 769

   

7. Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis

   • Ziyu Wang
   • Noriho Iida
   • Shuichi Kaneko

   Original Article—Alimentary Tract 26 July 2022 Pages: 770 - 783

   

8. LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression

   • Tieju Liu
   • Shihan Liao
   • Xiulan Zhao

   Original Article―Liver, Pancreas, and Biliary Tract 08 July 2022 Pages: 784 - 797

   

9. Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas

   • Taishu Kanda
   • Taiichi Wakiya
   • Kenichi Hakamada

   Original Article―Liver, Pancreas, and Biliary Tract Open access 03 July 2022 Pages: 798 - 811

   

10. Is it necessary for endoscopic surveillance for achalasia patients?

    • Huifang Xia
    • Yan Peng
    • Xiaowei Tang

    Letter to the Editor 24 August 2022 Pages: 812 - 812

11. Reply: Need for evidence on surveillance endoscopy in achalasia-related Barret esophagus and adenocarcinoma in Asian population

    • Hiroki Sato
    • Yuto Shimamura
    • Haruhiro Inoue

    Letter to the Editor 24 August 2022 Pages: 813 - 814

12. “Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection

    • Katsuro Ichimasa
    • Shin-ei Kudo
    • Khay Guan Yeoh

    Editorial 12 August 2022 Pages: 815 - 816

13. Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis

    • Qunfang Zhou
    • Xiaohui Wang
    • Ping Liang

    Correction Open access 03 August 2022 Pages: 817 - 817